The Scripps Research Institute has named Dale Boger, PhD, as chair of its Department of Chemistry. In addition, Thomas Kodadek, PhD, has been appointed vice chair.
TSRI’s Department of Chemistry is comprised of scientists on both coasts. Boger is based in the institute’s La Jolla, CA, campus, and Kodadek in the Jupiter, FL, campus.
“I am delighted that Dale and Tom have agreed to serve our Department of Chemistry—one of the most outstanding group of chemists in the world,” said Michael A. Marletta, PhD, president of TSRI and a faculty member in the Department of Chemistry. “Dale and Tom are outstanding scientists with vision, and I am very excited to work with both of them as we move chemistry ahead. It’s unique to have a chemistry department within a biomedical research institute and ours is an essential part of TSRI. I am confident Dale and Tom are the right leaders for the future.”
“I look forward to working with Dale to foster continued excellence in organic chemistry and chemical biology at Scripps on both coasts,” Kodadek said.
Kodadek, 53, received a bachelor’s degree in chemistry at the University of Miami (1981) and a PhD in organic chemistry from Stanford University (1985). He completed postdoctoral work in biochemistry the University of California, San Francisco, and joined the University of Texas, Austin, as an assistant professor in 1987. He joined the University of Texas Southwestern Medical Center as a professor of Internal Medicine and Molecular Biology in 1998 and became director of the Division of Translational Research in 2005.
At Scripps Florida, Kodadek holds joint appointments in the Departments of Chemistry and Cancer Biology.
Kodadek has made fundamental discoveries in nucleic acid enzymology, including elucidating the biochemistry of homologous genetic recombination and the role of the proteasome in eukaryotic transcription. His more recent research is focused on developing chemical tools to address important problems in biology and medicine, for example identifying synthetic molecules capable of targeting antibodies, B cells and T cells in an antigen-like fashion for the purpose of monitoring and manipulating the immune system.
His awards and honors include the Jane Coffin Childs Postdoctoral Fellowship; American Cancer Society Junior Faculty Research Award; NIH Director’s Pioneer Award. He is also an elected fellow of the American Association for the Advancement of Science.